Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Gains from Investment Securities (2016 - 2025)

Regenxbio has reported Gains from Investment Securities over the past 12 years, most recently at $122000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $122000.0 for Q4 2025, down 98.14% from a year ago — trailing twelve months through Dec 2025 was $10.7 million (down 3.08% YoY), and the annual figure for FY2025 was $801000.0, down 91.99%.
  • Gains from Investment Securities for Q4 2025 was $122000.0 at Regenxbio, down from $755306.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for RGNX hit a ceiling of $11.8 million in Q1 2025 and a floor of -$4.1 million in Q4 2021.
  • Median Gains from Investment Securities over the past 5 years was $1.2 million (2022), compared with a mean of $2.8 million.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 5823.61% in 2021 and later skyrocketed 16561.97% in 2025.
  • Regenxbio's Gains from Investment Securities stood at -$4.1 million in 2021, then soared by 111.19% to $461000.0 in 2022, then surged by 753.15% to $3.9 million in 2023, then surged by 66.69% to $6.6 million in 2024, then plummeted by 98.14% to $122000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $122000.0 (Q4 2025), $755306.0 (Q3 2025), and $2.4 million (Q2 2025) per Business Quant data.